Perceptive Advisors’s Five Prime Therapeutics FPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding FPRX
Perceptive Advisors's FPRX Position: Q2 2017 in Review
Perceptive Advisors sold out of Five Prime Therapeutics (FPRX) in Q2 2017, closing a stake of 127 shares — an estimated $5K sold.
Perceptive Advisors first reported a position in FPRX in Q4 2013 and held it in 14 quarters. The position peaked at $18.5M in Q1 2016. 123 funds tracked by Wall St. Rank hold FPRX as of Q2 2017.
- Perceptive Advisors reported no remaining Five Prime Therapeutics position as of Q2 2017 after selling out during the quarter.
- Perceptive Advisors sold 127 Five Prime Therapeutics shares in Q2 2017, an estimated $5K.
- Perceptive Advisors first reported a position in Five Prime Therapeutics in Q4 2013 and held it in 14 quarters.
- Perceptive Advisors's Five Prime Therapeutics position peaked at $18.5M in Q1 2016.
- 123 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q2 2017.
Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.